US court orders wider access for morning-after pill (Update 2)
After a decade-long battle over access to emergency contraception, a federal judge ordered US regulators Friday to make the morning-after pill available over the counter without age limits.
Medications
Apr 05, 2013 |
not rated yet |
0
Fecal microbial transplantation found to be possible treatment
A Spectrum Health clinical trial has found that fecal microbial transplantation (FMT) has resulted in the improvement or absence of symptoms in most pediatric patients with active ulcerative colitis.
Diseases, Conditions, Syndromes
Apr 05, 2013 |
not rated yet |
0
FDA says longer use of nicotine gum is OK
The Food and Drug Administration says smokers that are trying to quit can safely use nicotine gum, patches and lozenges for longer than previously recommended.
Health
Apr 01, 2013 |
not rated yet |
0
US approves new multiple sclerosis capsules
The U.S. Food and Drug Administration said Wednesday it approved a new drug from Biogen Idec to control multiple sclerosis in adults with hard-to-treat forms of the disease.
Medications
Mar 27, 2013 |
not rated yet |
0
Merck: FDA reviewing tablet to eliminate allergy
Drugmaker Merck & Co. says federal regulators are reviewing its application to sell a new type of treatment for grass pollen allergy that gradually reduces allergy symptoms over time, rather than just temporarily relieving ...
Immunology
Mar 27, 2013 |
4 / 5 (1) |
0
Judges side with FDA in rejecting stem cell device
(AP)—A federal appeals court is siding with the Food and Drug Administration in a case brought by medical device maker Cytori, ruling that the agency was correct to reject fast-track approval for two company devices used ...
Medications
Mar 22, 2013 |
3.7 / 5 (3) |
1
FDA proposes new rules for heart defibrillators
(AP)—The Food and Drug Administration will require makers of heart-zapping defibrillators to submit more data on their safety and effectiveness following years of recalls of the emergency devices.
Cardiology
Mar 22, 2013 |
not rated yet |
0
FDA: Georgia pharmacy recalling all sterile drugs
(AP)—The Food and Drug Administration says a Georgia compounding pharmacy that distributed a drug linked to eye infections is now recalling all of its injectable medicines following a federal inspection.
Medications
Mar 21, 2013 |
not rated yet |
0
Dotarem approved for nervous system MRIs
(HealthDay)—Dotarem (gadoterate meglumine) has been approved by the U.S. Food and Drug Administration as a contrast agent for use in MRIs of the brain, spine and other parts of the central nervous system.
Medications
Mar 21, 2013 |
5 / 5 (1) |
0
FDA warns of another compounding pharmacy recall
(AP)—The Food and Drug Administration is warning doctors that a compounding pharmacy is recalling syringes of the Roche drug Avastin after receiving reports of eye infections among patients.
Medications
Mar 20, 2013 |
not rated yet |
0
NY court: Group can sue over soap chemical
(AP)—A New York federal appeals court says environmental activists can try to prove that a chemical found in some soaps is potentially dangerous.
Health
Mar 15, 2013 |
not rated yet |
0
CWRU spinoff ConservoCare gets licensing options to develop medical device for bladder control
ConservoCare, LLC, a spinoff of research at Case Western Reserve University, has obtained license options through the university's Technology Transfer Office to develop a medical device for bladder control.
Other
Mar 15, 2013 |
not rated yet |
0
Rules must evolve to allow new drugs for early Alzheimer's
(HealthDay)—Given the shift in the focus of drug development for Alzheimer's disease toward earlier disease stages, before the onset of dementia, regulatory guidelines need to evolve, according to a perspective ...
Alzheimer's disease & dementia
Mar 14, 2013 |
4 / 5 (2) |
0
US probes new pancreas risks with diabetes drugs (Update)
The U.S. Food and Drug Administration is looking into new evidence that suggests a group of recently approved diabetes drugs can increase the risk of pancreatitis and other problems.
Medications
Mar 14, 2013 |
not rated yet |
0
Lymphoseek approved to help locate lymph nodes
(HealthDay)—The injected imaging drug Lymphoseek (technetium Tc 99m tilmanocept) has been approved by the U.S. Food and Drug Administration to help surgeons locate the lymph nodes among people with breast cancer or melanoma.
Cancer
Mar 13, 2013 |
not rated yet |
0
